Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Altimmune Stock Is Perking Up Today

TheMotleyFool

0 0

Why Altimmune Stock Is Perking Up TodayPhoto, wide shot, wide-angle lens, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png

Shares of the developmental stage biotech Altimmune (NASDAQ: ALT) jumped by as much as 17.8% in pre-market trading Tuesday morning. The biotech's shares are perking up this morning in response to the pre-publication of an animal study for its intranasal COVID-19 vaccine candidate known as AdCOVID.

The manuscript is currently available on the pre-print biology server BioRxiv.org. Altimmune is developing AdCOVID in conjunction with the University of Alabama at Birmingham.

Image source: Getty Images.

Source Fool.com

Like: 0

ALT

Share